Hepatocellular Carcinoma: Perspectives on Disparities in Care and Managed Care Considerations in an Evolving Treatment Landscape
This discussion will highlight recently approved and emerging therapeutic options in the HCC treatment landscape and address resource utilization strategies for managed care professionals to consider when determining the most appropriate management plans for patients.
Assessing the Value of New Treatment Strategies in Inflammatory Bowel Disease: A Review of Clinical Data and Managed Care Implications
Identify various treatment strategies that managed care professionals can implement to help improve patient adherence, clinical outcomes, and decrease healthcare costs associated with IBD.
Prospects of S1P Inhibitors for Treatment of Ulcerative Colitis: What Pharmacists Need to Know
This activity will review the importance of managing patient expectations and investigate the potential place of S1P inhibitors in the UC treatment paradigm.
Gastrointestinal Cancers: Managed Care Strategies to Improve Resource Utilization With Immune Checkpoint Inhibitors
This activity will explain the influence biomarker testing assays have on the overall cost of drug therapy for patients with gastrointestinal (GI) cancer who are receiving treatment with an immune checkpoint inhibitor.